Review examines circular RNA roles and biomarker prospects in liver cancer

Research update — AI-assisted summary of research by the cited authors.

A review examines how circular RNAs may be involved in hepatocellular carcinoma, including changes in cellular metabolism, immune escape and ferroptosis, a form of regulated cell death. The authors also discuss circular RNAs in blood and extracellular vesicles as potential diagnostic, prognostic and treatment-response biomarkers. They highlight challenges that must be addressed before routine clinical use.

Limits of the evidence

This is a review of existing research, not a new clinical trial or validation of a ready-to-use diagnostic test. Proposed molecular roles and biomarker associations do not establish that measuring or targeting a circular RNA improves patient outcomes. This summary covers the published abstract and bibliographic metadata only, not the full review or personal testing or treatment guidance. Based on published abstracts; details beyond those abstracts have not been checked.

Original sources

• Jinli Wang and colleagues. Circular RNAs as diagnostic biomarkers and therapeutic regulators of metabolic reprogramming, immune escape and ferroptosis in hepatocellular carcinoma. Clinica Chimica Acta 593, 121285 (2027). (2026-08-17)

This is research information, not personal medical advice.